Rhee SJ, Lee JW, Yu KS, Hong KT, Choi JY, Hong CR, Park KD, Shin HY, Song SH, Kang HJ, Lee H. Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram. American Journal of Hematology. 2017 Mar 28. doi: 10.1002/ajh.24734. [Epub ahead of print]

Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, Yu KS. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects. Drug design, development and therapy. 2015;9:729-736.

Jang K, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, Lee H. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state. Drug design, development and therapy. 2014;8:851-858.

Cha Y-J, Lee H, Gu N, Kim T-E, Lim KS, Yoon SH, Chung J-Y, Jang I-J, Shin S-G, Yu K-S, Cho J-Y. Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants. Basic Clin Pharmacol Toxicol. 2013;113(6):419-424.

Lee H, Kim KS, Chae SC, Jeong MH, Kim DS, Oh BH. Ambulatory Blood Pressure Response to Once-Daily Fimasartan: An 8-Week, Multicenter, Randomized, Double-Blind, Active-Comparator, Parallel-Group Study in Korean Patients With Mild To Moderate Essential Hypertension. Clin Ther. 2013;35(9):1337-49. doi: 10.1016/j.clinthera.2013.06.021.

Lee H, Yang H-M, Lee H-Y, Kim J-J, Choi D-J, Seung K-B, Jeon E-S, Ha J-W, Rim S-J, Park JB, Shin J-H, Oh B-H. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther. 2012;34(6):1273-1289.

Chi YH, Lee H, Paik SH et al. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fimasartan, a Novel Angiotensin II Receptor Antagonist, Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects. Am J Cardiovasc Drugs. 2011 Oct 1. 1(5):335-46.

O’brien S, Lee H, Ritchey, AK. Once-Daily Enoxaparin in Pediatric Thromboembolism: A Dose Finding and Pharmacodynamics Study, Journal of Thrombosis and Haemostasis, 2007 Sep;5(9):1985-7.

Lee H. KW Lim, JH Park et al. A Survey of Industrial Perspectives on the Central Pharmaceutical Affairs Council\'s Review of Clinical Trial Protocols and Study Reports, Kor J Clin Pharmacol Ther, 1998; 6(1): 11-28.

Dr. Hyun A Lee is a Senior Manager at Medical & Lifecycle Safety Team in Samsung Bioepis. Dr. Lee was a BK21 Postdoctoral Researcher at the Graduate School of Convergence Science and Technology, Seoul National University. Dr. Lee studied at the Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, and she was also a trainee in clinical pharmacology at the Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital. Dr. Lee graduated from North Carolina State University (NCSU) in the USA with a master’s degree in biomathematics (2010).